CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial

Ju Hee Oh, Dae Won Jun, Hye Young Kim, Seung Min Lee, Eileen L. Yoon, Jungwook Hwang, Jung Hwan Park, Hanbi Lee, Wankyu Kim, Hyunsung Kim

Clin Mol Hepatol. 2022;28(3):497-509. Published online 2022 April 28 DOI: https://doi.org/10.3350/cmh.2022.0019

Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial

Ju Hee Oh, Dae Won Jun, Hye Young Kim, Seung Min Lee, Eileen L. Yoon, Jungwook Hwang, Jung Hwan Park, Hanbi Lee, Wankyu Kim, Hyunsung Kim

Clinical and Molecular Hepatology. 2022;28(3):497-509

Link1

Link2 Link3

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

Gábor Firneisz, Tímea Varga, Gabriella Lengyel, János Fehér, Dóra Ghyczy, Barna Wichmann, László Selmeci, Zsolt Tulassay, Károly Rácz, Anikó Somogyi

PLoS ONE. 2010;5(8):e12226

Link1

<p>Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease</p>

Lin Chen, Xiujuan Zhang, Li Zhang, Dongmei Zheng

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020;Volume 13:3507-3518

Link1 Link2

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice

Takayasu Ideta, Yohei Shirakami, Tsuneyuki Miyazaki, Takahiro Kochi, Hiroyasu Sakai, Hisataka Moriwaki, Masahito Shimizu

International Journal of Molecular Sciences. 2015;16(12):29207-29218

Link1

Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population

Tianpeng Zheng, Bo Chen, Liuxue Yang, Xueping Hu, Xiaoxi Zhang, Hongbo Liu, Linyuan Qin

Metabolism. 2017;73:125-134

Link1 Link2

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research

Quentin M. Anstee, Robert D. Goldin

International Journal of Experimental Pathology. 2006;87(1):1-16

Link1 Link2

Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease

Linda Ban, Nicholas Shackel, Susan McLennan

International Journal of Molecular Sciences. 2016;17(3):376

Link1

Non-alcoholic fatty liver disease

PAUL ANGULO, KEITH D LINDOR

Journal of Gastroenterology and Hepatology. 2002;17:S186-S190

Link1 Link2 Link3

Treatment of non-alcoholic fatty liver disease

ARUN J SANYAL

Journal of Gastroenterology and Hepatology. 2002;17:S385-S388

Link1 Link2 Link3

Non-alcoholic fatty liver disease

Ana C. TUYAMA, Charissa Y. CHANG

Journal of Diabetes. 2012;4(3):266-280

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.